Ultrasound Department, Pauline Gandel Women's Imaging Centre, The Royal Women's Hospital, Parkville, Vic., Australia.
Department of Gynaecology, The Royal Women's Hospital, Parkville, Vic., Australia.
BJOG. 2018 Apr;125(5):567-575. doi: 10.1111/1471-0528.14752. Epub 2017 Jun 19.
To review management options for nontubal ectopic pregnancies.
Retrospective cohort study.
Tertiary hospital in Melbourne, Australia.
A total of 100 nontubal pregnancies: 1 abdominal, 32 caesarean scar, 14 cervical, 41 cornual-interstitial, 12 ovarian.
Cases were classified according to ectopic site. Management categories were medical, surgical, combination or expectant. Use of minimally invasive approaches (ultrasound-guided intra-sac injections or selective surgical techniques) was identified. Primary management was considered to be successful if no further unplanned interventions were required.
Success of primary management and frequency of unplanned interventions.
A high rate of success (82%) was demonstrated for all management regimens, with minimal morbidity and no deaths occurring. A high success rate was shown when the primary management regimen was systemic methotrexate or ultrasound-guided intra-sac injection (88%). The success rate for primary surgical management was 57%. High success rates were reported for both primary management with ultrasound-guided injections or in combination with systemic methotrexate (94%) and for primary management with systemic methotrexate alone (81%). Seventy-five per cent of women managed with minimally invasive surgical approaches avoided the need for more extensive surgery, but required longer follow up and additional interventions.
Minimally invasive approaches were found to be safe and effective treatment for women desiring to conserve fertility. Ultrasound-guided intra-sac injection and laparoscopic ectopic removal procedures aimed at preserving reproductive organs should be included as minimally invasive primary management tools in addition to the well-recognised option of systemic methotrexate.
Nontubal ectopics: minimally invasive procedures a safe alternative to surgery in selected cases.
回顾非输卵管异位妊娠的治疗选择。
回顾性队列研究。
澳大利亚墨尔本的一家三级医院。
共 100 例非输卵管妊娠:1 例腹部,32 例剖宫产瘢痕,14 例宫颈,41 例宫角间质,12 例卵巢。
根据异位部位对病例进行分类。治疗类别为药物、手术、联合或期待治疗。确定是否使用微创方法(超声引导下囊内注射或选择性手术技术)。如果不需要进一步的计划外干预,则认为主要治疗成功。
主要治疗的成功率和计划外干预的频率。
所有治疗方案均显示出较高的成功率(82%),且发病率低,无死亡发生。当主要治疗方案为全身甲氨蝶呤或超声引导下囊内注射时,成功率较高(88%)。手术治疗的成功率为 57%。超声引导注射或联合全身甲氨蝶呤的主要治疗(94%)和全身甲氨蝶呤单独的主要治疗(81%)成功率均较高。75%接受微创手术治疗的妇女避免了需要更广泛手术的需要,但需要更长时间的随访和额外的干预。
微创方法被认为是希望保留生育能力的妇女的安全有效治疗方法。除了全身甲氨蝶呤这一公认的选择之外,还应将超声引导下囊内注射和腹腔镜异位妊娠切除等旨在保留生殖器官的手术作为微创的主要治疗手段。
非输卵管异位妊娠:微创治疗在某些情况下是手术的安全替代方法。